Invivo therapeutics announces presentation at upcoming m vest llc and maxim group llc inaugural emerging growth virtual conference

Cambridge, mass.--(business wire)--invivo therapeutics holdings corp. (nasdaq: nviv), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that richard toselli, m.d., president and chief executive officer, will present at the upcoming m vest llc and maxim group llc inaugural emerging growth virtual conference, which runs from march 17 – march 19 from 9:00 am – 5:00 pm et. dr. toselli's presentation will provi
NVIV Ratings Summary
NVIV Quant Ranking